logo-loader
NASDAQ:ADAP

Adaptimmune Therapeutics PLC

Market:
NASDAQ
Market Cap:
$759.96 m
Price
4.91 USD
Change
6.51%
52 weeks high
13.39
52 weeks low
0.96

In brief

Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for cancer patients.